Decisional outcomes following use of an interactive web-based decision aid for prostate cancer screening.

Informed decision-making tools are recommended for men considering prostate cancer screening.

We evaluated the extent to which use of an interactive, web-based decision aid was associated with decisional and screening outcomes. P

articipants (N = 253) were 57 (7.0) years old and completed telephone interviews at baseline, 1 month, and 13 months post-baseline. Tracking software captured minutes spent on the website (median = 33.9), sections viewed (median = 4.0/5.0), testimonials viewed (median = 4.0/6.0), and values clarification tool (VCT) use (77.3 %). In multivariable analyses, all four website use variables were positively associated with increased knowledge (p's < 0.05). Complete VCT use and number of informational sections were positively associated with greater decisional satisfaction (p's < 0.05).

Decisional conflict and screening behavior were not associated with measures of website use. Increased use of informational content and interactive elements were related to improved knowledge and satisfaction. Methods to increase utilization of interactive website components may improve informed decision-making outcomes.

Transl Behav Med. 2015 Jun;5(2):189-97. doi: 10.1007/s13142-014-0301-0.

Tomko C1, Davis K1, Ludin S1, Kelly S1, Stern A1, Luta G2, Taylor KL1.

1 Cancer Prevention and Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC USA.
2 Lombardi Comprehensive Cancer Center, Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University Medical Center, Washington, DC USA.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe